T2	Disorder 9 51	Dihydropyrimidine dehydrogenase deficiency
N1 	Reference T2 UMLS:C1959620	Dihydropyrimidine dehydrogenase deficiency
T3	Pharmacological_substance 114 128	5-fluorouracil
N1000 	Reference T3 MeSH:D005472	5-fluorouracil
T6	Disorder 214 245;252 262	dihydropyrimidine dehydrogenase deficiency
N2 	Reference T6 UMLS:C1959620	dihydropyrimidine dehydrogenase deficiency
T7	Disorder 296 302	cancer
N3 	Reference T7 UMLS:C0006826	cancer
N4 	Reference T7 UMLS:C1306459	cancer
T8	Pharmacological_substance 353 367	5-fluorouracil
N1001 	Reference T8 MeSH:D005472	5-fluorouracil
T9	Pharmacological_substance 369 373	5-FU
N1002 	Reference T9 MeSH:D005472	5-FU
N1003 	Reference T9 MeSH:D005472	5-FU
T11	Disorder 612 618	cancer
N5 	Reference T11 UMLS:C0006826	cancer
N6 	Reference T11 UMLS:C1306459	cancer
T12	Disorder 696 704	diarrhea
N7 	Reference T12 UMLS:C0011991	diarrhea
T13	Disorder 706 716	stomatitis
N8 	Reference T13 UMLS:C0038362	stomatitis
T14	Disorder 718 727	mucositis
N9 	Reference T14 UMLS:C0333355	mucositis
T15	Disorder 729 745	myelosuppression
N10 	Reference T15 UMLS:C0854467	myelosuppression
T16	Disorder 747 760	neurotoxicity
N11 	Reference T16 UMLS:C0235032	neurotoxicity
T17	Pharmacological_substance 783 787	5-FU
N1004 	Reference T17 MeSH:D005472	5-FU
N1005 	Reference T17 MeSH:D005472	5-FU
T18	Disorder 802 816	DPD deficiency
N12 	Reference T18 UMLS:C1959620	DPD deficiency
N13 	Reference T18 UMLS:C1959620	DPD deficiency
T20	Pharmacological_substance 1003 1012	thymidine
N1006 	Reference T20 MeSH:D013936	thymidine
T21	Disorder 1057 1076	neurologic symptoms
N14 	Reference T21 UMLS:C0235031	neurologic symptoms
T22	Disorder 1085 1099	encephalopathy
N15 	Reference T22 UMLS:C0085584	encephalopathy
T23	Disorder 1104 1108	coma
N16 	Reference T23 UMLS:C0009421	coma
T24	Disorder 1276 1286	toxicities
N17 	Reference T24 UMLS:C0600688	toxicities
T25	Disorder 1438 1469	traumatic psychosocial stresses
T27	Disorder 1513 1519	cancer
N18 	Reference T27 UMLS:C0006826	cancer
N19 	Reference T27 UMLS:C1306459	cancer
T28	Pharmacological_substance 1530 1534	5-FU
N1007 	Reference T28 MeSH:D005472	5-FU
N1008 	Reference T28 MeSH:D005472	5-FU
T31	Pharmacological_substance 554 558	5-FU
N1009 	Reference T31 MeSH:D005472	5-FU
N1010 	Reference T31 MeSH:D005472	5-FU
T33	Subject 584 606	3% or more of patients
T34	Disorder 664 688	severe adverse reactions
N20 	Reference T34 UMLS:C0559546	severe adverse reactions
T35	Pharmacological_substance 1044 1048	5-FU
N1011 	Reference T35 MeSH:D005472	5-FU
N1012 	Reference T35 MeSH:D005472	5-FU
T36	Pharmacological_substance 937 941	5-FU
N1013 	Reference T36 MeSH:D005472	5-FU
N1014 	Reference T36 MeSH:D005472	5-FU
T37	Disorder 55 77	pharmacogenetic defect
T38	Disorder 318 342	lethal adverse reactions
T40	Subject 282 290	patients
T41	Disorder 484 504	Genetic deficiencies
T43	Speculation_cue 645 649	risk
T44	Subject 896 918	DPD-deficient patients
T45	Disorder 924 951	severe acute 5-FU reactions
T48	Speculation_cue 1025 1028	may
T50	Subject 1485 1507	DPD-deficient patients
T54	Disorder 1157 1181	pharmacogenetic syndrome
